Current and emerging medical therapies in the treatment of glaucoma.
about
Current perspective of neuroprotection and glaucomaDifferent strategies and cost-effectiveness in the treatment of primary open angle glaucoma.Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker MonotherapyBenefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trialsAntiglaucoma drugs: The role of preservative-free formulations.Adenosine A1 modulators: a patent update (2008 to present).Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenonLong Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye DropRetinal Astrocytes and GABAergic Wide-Field Amacrine Cells Express PDGFRα: Connection to Retinal Ganglion Cell Neuroprotection by PDGF-AA.Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patients.Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting.
P2860
Q26774852-2680A7AF-E995-41DB-94C0-620CA626A042Q34657160-99E9BD59-80BC-48D8-9FD4-FFEC611B6340Q36291171-E51A1A3F-40DC-4EDF-8B36-65F900276C25Q36710059-D413B250-C184-4873-A4E2-50B49F693186Q37060734-1141191A-A3BA-4849-BFFA-79976C3DD4C5Q38109907-7DD5B6A9-06D9-414C-9915-A43106FC5289Q38166800-626EB5A8-5887-46B7-9940-9CCAFA921537Q38584194-A30CE22C-E669-44EB-BE53-B34A87B9E0DBQ38797407-33E73C20-3547-4FE6-9156-8C220AEF3429Q41448579-DBB75572-A53B-427D-80E6-308659DBED96Q41706399-CE0DB859-13BA-4DE6-BAC7-CD8D445C7202Q42703310-772F19EF-A0B5-474B-A6CF-43B2DA5476F3Q47954026-FF28D556-7687-4293-8971-3ADB682F6E9DQ52995234-78049F00-8BE8-48C4-A4E9-848EAB869E48
P2860
Current and emerging medical therapies in the treatment of glaucoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current and emerging medical therapies in the treatment of glaucoma.
@en
Current and emerging medical therapies in the treatment of glaucoma.
@nl
type
label
Current and emerging medical therapies in the treatment of glaucoma.
@en
Current and emerging medical therapies in the treatment of glaucoma.
@nl
prefLabel
Current and emerging medical therapies in the treatment of glaucoma.
@en
Current and emerging medical therapies in the treatment of glaucoma.
@nl
P2093
P2860
P1476
Current and emerging medical therapies in the treatment of glaucoma.
@en
P2093
Alessandro Bagnis
Carlo E Traverso
Marina Papadia
Riccardo Scotto
P2860
P304
P356
10.1517/14728214.2011.563733
P407
P577
2011-04-07T00:00:00Z